Wall Street Analysts Think TFF Pharmaceuticals, Inc. (TFFP) Could Surge 233%: Read This Before Placing a BetZacks Investment Research • 05/31/22
TFF Pharmaceuticals to Participate at the H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 05/20/22
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22
TFF Pharmaceuticals, Inc. (TFFP) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/11/22
TFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 05/11/22
TFF Pharmaceuticals Announces Multiple Presentations Highlighting Broad Applicability of its Thin Film Freezing Technology at Respiratory Drug Delivery Meeting (RDD)GlobeNewsWire • 05/02/22
TFF Pharmaceuticals to Hold First Quarter 2022 Financial and Business Results Conference Call on May 11, 2022GlobeNewsWire • 04/29/22
TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study of Niclosamide Inhalation PowderGlobeNewsWire • 04/19/22
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/25/22
TFF Pharmaceuticals, Inc. (TFFP) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/24/22
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdateGlobeNewsWire • 03/24/22
TFF Pharmaceuticals Enters into CRADA with the U.S. Army and The Geneva Foundation to Develop Dry Powder Needle-free Medical CountermeasuresGlobeNewsWire • 03/17/22
TFF Pharmaceuticals to Hold Fourth Quarter and Full Year 2021 Financial and Business Results Conference Call on March 24, 2022GlobeNewsWire • 03/09/22
TFF Pharmaceuticals and Catalent Announce New Inhalation Dry Powder Development and Manufacturing AgreementGlobeNewsWire • 03/01/22
TFF Pharmaceuticals Announces Inhaled Niclosamide Significantly Inhibits Viral Replication of the Omicron Variant of SARS-CoV-2GlobeNewsWire • 02/24/22
TFF Pharmaceuticals Completes Enrollment in Phase 1 Study Evaluating Inhaled Formulation of Niclosamide to Treat COVID-19GlobeNewsWire • 01/27/22
Recently Revealed Pfizer Collaboration Might Just Be What The Doctor Ordered For TFF PharmaceuticalsBenzinga • 01/10/22
TFF Pharmaceuticals Announces Final Data from Phase 1b Study of Inhaled Voriconazole Powder in Asthma PatientsGlobeNewsWire • 12/21/21
TFF Pharmaceuticals: Upside Catalysts Starting To Show Up Amid Omicron, But TimidlySeeking Alpha • 12/02/21
TFF Pharmaceuticals, Inc. (TFFP) CEO Glenn Mattes on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/16/21